AngioDynamics, Inc. (ANGO)
16.13
+0.28
(+1.77%)
USD |
NASDAQ |
Aug 31, 16:00
16.13
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Cash from Operations (TTM) : 3.089M for May 31, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | 3.089M |
| February 28, 2026 | 3.768M |
| November 30, 2025 | -6.281M |
| August 31, 2025 | -8.469M |
| May 31, 2025 | -10.81M |
| February 28, 2025 | -23.94M |
| November 30, 2024 | -23.30M |
| August 31, 2024 | -20.51M |
| May 31, 2024 | -28.16M |
| February 29, 2024 | -16.45M |
| November 30, 2023 | -2.558M |
| August 31, 2023 | -0.37M |
| May 31, 2023 | 0.078M |
| February 28, 2023 | -8.067M |
| November 30, 2022 | -18.23M |
| August 31, 2022 | -23.74M |
| May 31, 2022 | -7.194M |
| February 28, 2022 | -3.555M |
| November 30, 2021 | 11.11M |
| August 31, 2021 | 20.61M |
| May 31, 2021 | 24.09M |
| February 28, 2021 | 15.77M |
| November 30, 2020 | -7.193M |
| August 31, 2020 | -12.70M |
| May 31, 2020 | -14.55M |
| Date | Value |
|---|---|
| February 29, 2020 | 6.578M |
| November 30, 2019 | 32.02M |
| August 31, 2019 | 39.04M |
| May 31, 2019 | 37.44M |
| February 28, 2019 | 36.20M |
| November 30, 2018 | 32.17M |
| August 31, 2018 | 29.38M |
| May 31, 2018 | 41.29M |
| February 28, 2018 | 36.51M |
| November 30, 2017 | 46.56M |
| August 31, 2017 | 51.34M |
| May 31, 2017 | 55.74M |
| February 28, 2017 | 55.30M |
| November 30, 2016 | 53.32M |
| August 31, 2016 | 47.96M |
| May 31, 2016 | 45.22M |
| February 29, 2016 | 37.48M |
| November 30, 2015 | 37.32M |
| August 31, 2015 | 25.59M |
| May 31, 2015 | 26.24M |
| February 28, 2015 | 24.94M |
| November 30, 2014 | 12.13M |
| August 31, 2014 | 22.73M |
| May 31, 2014 | 24.68M |
| February 28, 2014 | 26.54M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Boston Scientific Corp. | 4.529B |
| Penumbra, Inc. | 277.80M |
| Abbott Laboratories | 9.905B |
| Alphatec Holdings, Inc. | 56.52M |
| AtriCure, Inc. | 64.94M |